People · Operator
Named in public records as an officer, director or promoter · active 2009–2018 · Other Health Care, Healthtech, Other Technology, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Endologix Inc /De/ | — | Other Health Care | Series D+ | $420.0M | $4.8B | 2018 |
| Acutus Medical, Inc. | — | Healthtech | Series D+ | $296.3M | $68.9M | 2016 |
| Oraya Therapeutics Inc | — | Other Technology | Series B | $74.9M | $765.4M | 2009 |
| Barosense Inc | — | Biotechnology | Series B | $56.9M | $1.2B | 2009 |
John Onopchenko at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside John Onopchenko on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Kevin Johnson | 1 | 12 |
| James Taylor | 1 | 12 |
| Brian Halak | 1 | 10 |
| Peter Cohn | 1 | 10 |
| Steven Hochberg | 1 | 9 |
| Alan Levy | 1 | 7 |
| Andrew ElBardissi | 1 | 7 |
| Reza Zadno | 1 | 7 |
| Scott Huennekens | 1 | 7 |
| Guido Neels | 1 | 7 |
| David Bonita | 1 | 6 |
| Leslie V. Norwalk | 1 | 5 |
| Mark Brooks | 1 | 5 |
| John McDermott | 1 | 5 |
| Gregory D. Waller | 1 | 4 |
| Robert D Mitchell | 1 | 4 |
| Shahzad Malik | 1 | 4 |
| Eric Linsley | 1 | 4 |
| Aditya Puri | 1 | 4 |
| Jeffrey F. O'Donnell | 1 | 3 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.